Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder

Jingjing Pan1, Xu Li2, Wenjing Wu1

  • 1Department of Clinical Laboratory, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

Cancer Letters
|September 5, 2016
PubMed

Insights

Chemoresistance in bladder cancer is a major challenge. This study reveals that Urothelial Cancer Associated 1 (UCA1) long non-coding RNA promotes chemoresistance by activating CREB and miR-196a-5p, suggesting UCA1 as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Chemoresistance is a primary obstacle in bladder cancer treatment, with underlying molecular mechanisms remaining largely unknown.
  • Long non-coding RNAs (lncRNAs) are increasingly recognized for their role in modulating cellular responses to chemotherapy.
  • Urothelial Cancer Associated 1 (UCA1), a lncRNA, is upregulated in bladder cancer and linked to tumor progression and drug resistance.

Purpose of the Study:

  • To elucidate the role of Urothelial Cancer Associated 1 (UCA1) in chemoresistance to cisplatin and gemcitabine in bladder cancer.
  • To investigate the molecular pathway through which UCA1 influences chemosensitivity.
  • To assess the potential of UCA1 as a therapeutic target for overcoming chemoresistance in bladder cancer.

Main Methods:

  • Investigated the effect of UCA1 knockdown and overexpression on bladder cancer cell sensitivity to cisplatin and gemcitabine.
  • Analyzed UCA1's impact on cell proliferation and apoptosis.
  • Explored the regulatory relationship between UCA1, CREB, miR-196a-5p, and p27Kip1 using molecular biology techniques.

Main Results:

  • Knockdown of UCA1 reduced chemosensitivity by suppressing proliferation and inducing apoptosis.
  • Overexpression of UCA1 enhanced chemosensitivity in bladder cancer cells.
  • UCA1 was found to activate CREB, leading to miR-196a-5p expression, which in turn targets p27Kip1, thereby inhibiting apoptosis induced by chemotherapy.

Conclusions:

  • A novel UCA1-CREB-miR-196a-5p signaling axis partially explains UCA1's function in cisplatin/gemcitabine resistance.
  • UCA1 plays a significant role in conferring chemoresistance in bladder cancer.
  • UCA1 represents a promising therapeutic target for improving chemotherapy efficacy in bladder cancer patients.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.0K
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.8K